These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11822618)

  • 1. Ethical issues regarding fee-for-service-funded research within a complementary medicine context.
    Evans S; Block JB
    J Altern Complement Med; 2001 Dec; 7(6):697-702. PubMed ID: 11822618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in complementary/alternative therapies.
    Silva MC; Ludwick R
    Online J Issues Nurs; 2002; 7(1):7. PubMed ID: 12044217
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical dimensions in the borderland between conventional and complementary/alternative medicine.
    Thorne S; Best A; Balon J; Kelner M; Rickhi B
    J Altern Complement Med; 2002 Dec; 8(6):907-15. PubMed ID: 12614541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and alternative medicine in outcomes research.
    Riley D; Berman B
    Altern Ther Health Med; 2002; 8(3):36-7. PubMed ID: 12017498
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States.
    Cohen MH; Hrbek A; Davis RB; Schachter SC; Kemper KJ; Boyer EW; Eisenberg DM
    Arch Intern Med; 2005 Feb; 165(3):289-95. PubMed ID: 15710791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer access to research on dietary supplements: a database of federally funded dietary supplement research.
    Haggans CJ; Regan KS; Brown LM; Wang C; Krebs-Smith J; Coates PM; Swanson CA
    J Nutr; 2005 Jul; 135(7):1796-9. PubMed ID: 15987867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical issues arising from medical research.
    Hamilton MP
    Isr J Med Sci; 1983 May; 19(5):431-6. PubMed ID: 6345463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limitations of "vulnerability" as a protection for human research participants.
    Levine C; Faden R; Grady C; Hammerschmidt D; Eckenwiler L; Sugarman J;
    Am J Bioeth; 2004; 4(3):44-9. PubMed ID: 16192138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Private enterprise and public good: ethical issues in the funding of clinical research.
    Williams AH; Rowell M
    Ann R Coll Physicians Surg Can; 1999 Jun; 32(4):227-31. PubMed ID: 12385289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IOM points to need for more research, regulation in alternative medicine.
    Voelker R
    JAMA; 2005 Mar; 293(10):1178-80. PubMed ID: 15755931
    [No Abstract]   [Full Text] [Related]  

  • 15. IOM report recommends continued CAM research and stricter regulation of dietary supplements.
    Horrigan BJ
    Explore (NY); 2005 May; 1(3):159-65. PubMed ID: 16781522
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
    Kantor M
    J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fee-for-service research.
    N Engl J Med; 1986 Oct; 315(17):1099-100. PubMed ID: 3762628
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effectiveness research: does the emperor have clothes?
    Coulter ID
    Altern Ther Health Med; 2011; 17(2):8-15. PubMed ID: 21717820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary supplement survey of pharmacists: personal and professional practices.
    Howard N; Tsourounis C; Kapusnik-Uner J
    J Altern Complement Med; 2001 Dec; 7(6):667-80. PubMed ID: 11822615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.